These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 4716349)

  • 1. [Some functional consequences of the blood-brain barrier for catecholamines and their precursors].
    Tissot R; Gaillard JM; Constantinidis J; Geissbühler P
    Acta Physiol Pol; 1973; 24(1):61-70. PubMed ID: 4716349
    [No Abstract]   [Full Text] [Related]  

  • 2. [Selective increase of C14-catecholamines in the brain due to peripheral inhibition of decarboxylase].
    Bartholini G; Pletscher A; Burkard WP
    Helv Physiol Pharmacol Acta; 1967; 25(2):CR170-2. PubMed ID: 5588156
    [No Abstract]   [Full Text] [Related]  

  • 3. [Penetration of catecholamines through the blood-brain barrier].
    Zakusov VV; Vysotskaia NB; Tolmacheva NS
    Biull Eksp Biol Med; 1972 May; 73(5):64-6. PubMed ID: 5038314
    [No Abstract]   [Full Text] [Related]  

  • 4. Production of ( 3 H)catecholamines in the brain following the peripheal administration of 3 H-dopa during pre- and postnatal development.
    Kellogg C; Lundborg P
    Brain Res; 1972 Jan; 36(2):333-42. PubMed ID: 5061894
    [No Abstract]   [Full Text] [Related]  

  • 5. Decarboxylase activity of the brain capillary walls and parenchyma in the rat, cat and monkey.
    Langelier P; Parent A; Poirier LJ
    Brain Res; 1972 Oct; 45(2):622-9. PubMed ID: 4628637
    [No Abstract]   [Full Text] [Related]  

  • 6. Experimental evaluation of L-dopa penetration in brain.
    De la Torre JC; Mullan S
    Trans Am Neurol Assoc; 1971; 96():227-9. PubMed ID: 5159088
    [No Abstract]   [Full Text] [Related]  

  • 7. Studies on DL-5-hydroxytryptophan-induced hyperactivity in mice.
    Modigh K
    Adv Biochem Psychopharmacol; 1974; 10():213-7. PubMed ID: 4546515
    [No Abstract]   [Full Text] [Related]  

  • 8. Accumulation of 3H-homovanillic acid in rabbit brain and cerebrospinal fluid following intravenous 3H-L-dopa.
    Extein I; Roth RH; Bowers MB
    Biol Psychiatry; 1974 Oct; 9(2):161-70. PubMed ID: 4429746
    [No Abstract]   [Full Text] [Related]  

  • 9. [Biochemical and pharmacological study of 3-(2-morpholino-ethylamino) 4-methyl 6-phenyl pyridazine dihydrochloride (Agar 1240)].
    Laborit H; Brunaud M; Savy JM; Baron C; Vallée E; Lamothe C; Thuret F; Muyard JP; Calvino B
    Agressologie; 1972; 13(5):291-317. PubMed ID: 4653534
    [No Abstract]   [Full Text] [Related]  

  • 10. The role of the adrenergic system in the action of L-DOPA on brain serotonin.
    Algeri S; Cerletti C
    Adv Biochem Psychopharmacol; 1974; 10():257-9. PubMed ID: 4846542
    [No Abstract]   [Full Text] [Related]  

  • 11. Enhancement by 6-hydroxydopamine of the effects of DOPA upon the motor activity of rats.
    Schoenfeld RI; Uretsky NJ
    J Pharmacol Exp Ther; 1973 Sep; 186(3):616-24. PubMed ID: 4728340
    [No Abstract]   [Full Text] [Related]  

  • 12. [Recent acquisitions on cerebral metabolism of catecholamines].
    Glowinski J
    Actual Pharmacol (Paris); 1967; 20():29-68. PubMed ID: 4894123
    [No Abstract]   [Full Text] [Related]  

  • 13. [Potentiation of the central effect of DOPA after selective inhibition of extracerebral decarboxylase].
    Gaillard JM; Schaeppi R; Tissot R
    Arch Int Pharmacodyn Ther; 1969 Aug; 180(2):423-37. PubMed ID: 5348411
    [No Abstract]   [Full Text] [Related]  

  • 14. [Role of central catecholamines in blood pressure regulation of spontaneously hypertensive rat].
    Yamori Y
    Saishin Igaku; 1971 Nov; 26(11):2063-73. PubMed ID: 4946774
    [No Abstract]   [Full Text] [Related]  

  • 15. Biochemical changes in the brain of experimental animals in response to elevated plasma homocystine and methionine.
    Tudball N; Griffiths R
    J Neurochem; 1976 Jun; 26(6):1149-54. PubMed ID: 932720
    [No Abstract]   [Full Text] [Related]  

  • 16. [The capillary barrier for dopa in brain and different organs].
    Constantinidis J; De La Torre JC; Tissot R; Geissbuhler F
    Psychopharmacologia; 1969; 15(2):75-87. PubMed ID: 5351123
    [No Abstract]   [Full Text] [Related]  

  • 17. [Ketamine and catecholamine metabolism. 1. Dopamine metabolic turnover rate and L-DOPA].
    Goto F; Fujita T
    Masui; 1972 Jul; 21(7):642-7. PubMed ID: 4673201
    [No Abstract]   [Full Text] [Related]  

  • 18. A rapid fluorescence microscopic method for the study of the capillary DOPA-dopamine barrier.
    Jancsó G
    J Neurochem; 1975 Mar; 24(3):579-80. PubMed ID: 1113128
    [No Abstract]   [Full Text] [Related]  

  • 19. [In-vitro action of L-dopa (3-4 dihydroxyphenylalanine) on cerebral glutamate decarboxylase (GAD) and on -aminobutyric transaminase (GABA-T) in rats].
    Macaione S; Mattaliano G; Livrea P
    Boll Soc Ital Biol Sper; 1972 May; 48(9):216-21. PubMed ID: 5070092
    [No Abstract]   [Full Text] [Related]  

  • 20. Concurrent registration of EEG responses, catecholamine uptake and trypan blue staining in chemical blood-brain-barrier damage.
    Flodmark S; Hamberger A; Hamberger B; Steinwall O
    Acta Neuropathol; 1968 Dec; 12(1):17-22. PubMed ID: 5708545
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.